SEC Form 4 · accession 0001609351-18-000009
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Furey
Officer — Chief Operating Officer
Period of report
Dec 8, 2017
Accepted (ET)
Jan 22, 2018 · 7:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 8, 2017 | P | 18 | $73.48 | A | 18 | I | By mother-in-law |
| Common StockF1 | Dec 11, 2017 | S | 18 | $46.33 | D | 0 | I | By mother-in-law |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects transactions occurring in a brokerage account managed by an investment advisor who maintained discretionary authority over the account. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.